Copyright
©The Author(s) 2023.
World J Orthop. Apr 18, 2023; 14(4): 218-230
Published online Apr 18, 2023. doi: 10.5312/wjo.v14.i4.218
Published online Apr 18, 2023. doi: 10.5312/wjo.v14.i4.218
Table 2 Operative variables of the study cohort, including procedure type (primary vs revision), surgical indications, mode of failure according to the Henderson Classification, and number of previous knee surgeries on the operative knee, n (%)
Operative variable | Value |
Procedure type | |
Primary | 29 (52.7) |
Revision | 26 (47.3) |
Surgical indications | |
Osteogenic sarcoma | 22 (40.0) |
Giant cell tumor | 9 (16.4) |
Metastatic carcinoma | 8 (14.6) |
Soft-tissue sarcomaa | 4 (7.3) |
Chondrosarcoma | |
High-grade | 3 (5.5) |
Low-grade | 2 (3.6) |
Synovial chondromatosis | 2 (3.6) |
Multiple myeloma | 2 (3.6) |
Non-Hodgkin's lymphoma | 1 (1.8) |
Pigmented villonodular synovitis | 1 (1.8) |
Neoplasm of unspecified behavior | 1 (1.8) |
Primary mode of failure, henderson classification | |
Type 1 (soft-tissue failure) | 6 (10.9) |
Type 2 (aseptic loosening) | 5 (9.1) |
Type 3 (structural failure)b | 2 (3.6) |
Type 4 (periprosthetic infection) | 6 (10.9) |
Type 5 (tumor progression) | 1 (1.8) |
Number of previous surgeries (mean ± SD) | 1.1 ± 1.3 surgeries |
- Citation: Christ AB, Chung BC, Urness M, Mayer LW, Gettleman BS, Heckmann ND, Menendez LR. Clinical outcomes of cemented distal femur replacements with all-polyethylene tibial components for oncologic indications. World J Orthop 2023; 14(4): 218-230
- URL: https://www.wjgnet.com/2218-5836/full/v14/i4/218.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i4.218